BromSite 0.075% (Bromfenac)
BromSite (bromfenac ophthalmic solution) 0.075% is indicated for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery…
Sun Pharmaceutical Industries, Inc. Products: Prescription Medications Section, Page 4
Buprenorphine
Buprenorphine sublingual tablet is indicated for the treatment of opioid dependence and is preferred for induction. Buprenorphine sublingual tablet should be used as part of a complete…
Buprenorphine and Naloxone
Buprenorphine and naloxone sublingual tablet is indicated for the maintenance treatment of opioid dependence. Buprenorphine and naloxone sublingual tablet should be used as part of a…
Bupropion Hydrochloride
Bupropion hydrochloride extended-release tablets. USP (XL) is an aminoketone antidepressant, indicated for: treatment of major depressive disorder (MDD) (1.1) prevention of…
BYNFEZIA Pen (Octreotide Acetate)
BYNFEZIA Pen is a somatostatin analogue indicated for: Reduction of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) [somatomedin C] in adult patients with acromegaly who have…